drugset / Trial / NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NaSingle-groupOpen-labelOther
Summary
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Timeline
- Start
- 2025-11-05
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimekizumab | Monoclonal antibody | — | — |